When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRNS - Marinus gets new method of use patent approval for ganaxolone
Marinus Pharmaceuticals Inc.
2023-06-21 16:57:40 ET
Marinus Pharmaceuticals ( NASDAQ: MRNS ) said Wednesday that the United States Patent and Trademark Office has granted a new method of use patent for intravenous ganaxolone in the treatment of status epilepticus, expiring in 2040.
The company said corresponding patent applications are expected to be filed in several other key global markets and additional novel applications are pending for IV ganaxolone in SE in the U.S.